help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rothenberg, M. E.
Right arrow Articles by Noe, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rothenberg, M. E.
Right arrow Articles by Noe, B. D.

Molecular Endocrinology, Vol 10, 331-341, Copyright © 1996 by Endocrine Society


ARTICLES

Evidence for redundancy in propeptide/prohormone convertase activities in processing proglucagon: an antisense study

ME Rothenberg, CD Eilertson, K Klein, RB Mackin and BD Noe
Department of Anatomy and Cell Biology, Emory University, Atlanta, Georgia 30322, USA.

To further examine the physiological roles of the neuroendocrine prohormone convertases (PCs) in proglucagon processing, alpha TC1-6 cells were transiently transfected with PC1/3 and PC2 expression vectors containing either antisense or sense encoding cDNAs. PC1/3- and PC2-directed RIAs were used to determine that the PC1/3 antisense transfections lowered endogenous levels of PC1/3 by 40 +/- 7.9% but did not alter the levels of PC2. The PC2 antisense transfections decreased the endogenous levels of PC2 by 91 +/- 11.7% without affecting the levels of PC1/3. To quantitate the levels of proglucagon and proglucagon-derived products, transfected cells were metabolically labeled with [3H]tryptophan, and extracts were chromatographed by reversed-phase HPLC. Recovered peptides were then subjected to peptide mapping analyses, allowing precise quantification of 3H-radioactivity incorporated into proglucagon and its cleavage products. Product- precursor ratios were determined, and percent change in the proportion of products generated in antisense-transfected vs. sense-transfected cells was calculated. The decrease in PC1/3 after antisense treatment significantly reduced the amounts of glicentin produced and partially reduced the levels of all other proglucagon cleavage products. PC2 antisense treatment significantly reduced the levels of glicentin and 9K glucagon generated but had no significant effect on the remainder of the proglucagon-derived peptides. These results suggest the existence of redundant mechanisms that ensure the production of each of the intermediate and product peptides derived from proglucagon. PC1/3 is potentially an important enzyme in the processing of most proglucagon- derived peptides, whereas PC2-processing activity appears to predominate at only two of the four potential cleavage sites.


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Dey, G. M. Lipkind, Y. Rouille, C. Norrbom, J. Stein, C. Zhang, R. Carroll, and D. F. Steiner
Significance of Prohormone Convertase 2, PC2, Mediated Initial Cleavage at the Proglucagon Interdomain Site, Lys70-Arg71, to Generate Glucagon
Endocrinology, February 1, 2005; 146(2): 713 - 727.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Ugleholdt, X. Zhu, C. F. Deacon, C. Orskov, D. F. Steiner, and J. J. Holst
Impaired Intestinal Proglucagon Processing in Mice Lacking Prohormone Convertase 1
Endocrinology, March 1, 2004; 145(3): 1349 - 1355.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Lovshin, B. Yusta, I. Iliopoulos, A. Migirdicyan, L. Dableh, P. L. Brubaker, and D. J. Drucker
Ontogeny of the Glucagon-Like Peptide-2 Receptor Axis in the Developing Rat Intestine
Endocrinology, November 1, 2000; 141(11): 4194 - 4201.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. J. Kieffer and J. Francis Habener
The Glucagon-Like Peptides
Endocr. Rev., December 1, 1999; 20(6): 876 - 913.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
A. B. Damholt, A. M. J. Buchan, J. J. Holst, and H. Kofod
Proglucagon Processing Profile in Canine L Cells Expressing Endogenous Prohormone Convertase 1/3 and Prohormone Convertase 2
Endocrinology, October 1, 1999; 140(10): 4800 - 4808.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Viale, C. Ortola, G. Hervieu, M. Furuta, P. Barbero, D. F. Steiner, N. G. Seidah, and J.-L. Nahon
Cellular Localization and Role of Prohormone Convertases in the Processing of Pro-melanin Concentrating Hormone in Mammals
J. Biol. Chem., March 5, 1999; 274(10): 6536 - 6545.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Dhanvantari and P. L. Brubaker
Proglucagon Processing in an Islet Cell Line: Effects of PC1 Overexpression and PC2 Depletion
Endocrinology, April 1, 1998; 139(4): 1630 - 1637.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Furuta, H. Yano, A. Zhou, Y. Rouille, J. J. Holst, R. Carroll, M. Ravazzola, L. Orci, H. Furuta, and D. F. Steiner
Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2
PNAS, June 24, 1997; 94(13): 6646 - 6651.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Furuta, A. Zhou, G. Webb, R. Carroll, M. Ravazzola, L. Orci, and D. F. Steiner
Severe Defect in Proglucagon Processing in Islet A-cells of Prohormone Convertase 2 Null Mice
J. Biol. Chem., July 13, 2001; 276(29): 27197 - 27202.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society